University of Chicago Medicine Comprehensive Cancer Center | Strategic Alliance Partners

May 02, 2024

Drs Connell and Merkow discuss the current treatment landscape in intrahepatic cholangiocarcinoma and review recent clinical data in that space.

May 02, 2024

Louise Catherine Connell, MB BCh BAO, BMedSc, and Ryan Merkow, MD, MS, review clinical trial data on resected colorectal cancer liver metastases.

May 02, 2024

A surgical oncologist and gastrointestinal oncologist review data on hepatic artery infusion therapy in unresectable colorectal cancer liver metastases.

May 02, 2024

Two experts on gastrointestinal cancers give a broad overview of hepatic artery infusions.

May 02, 2024

Ryan Merkow, MD, MS, and Louise Catherine Connell, MB BCh BAO, BMedSc, discuss the current treatment landscape in colorectal cancer liver metastases, highlighting unmet needs in the treatment space.

May 02, 2024

Drs Merkow and Connell discuss the use of HAI therapy for patients with colorectal cancer.

April 30, 2024

Akriti Jain, MD, discusses the phase 1b VERONA study of venetoclax plus azacitidine in higher-risk myelodysplastic syndromes.

April 29, 2024

Rita Nanda, MD, discusses the importance of testing for HER2-low status in patients with early-stage breast cancer.

April 26, 2024

Rita Nanda, MD, discusses the evolution of treatment with CDK4/6 inhibitors in patients with hormone receptor-positive/HER2-negative breast cancer.

April 23, 2024

Rita Nanda, MD, discusses the evolution of treatment options for patients with HER2-low breast cancer.

April 18, 2024

Daniel Olson, MD, discusses toxicities associated with lifileucel and IL-2 in patients with unresectable or metastatic melanoma.

April 18, 2024

Nan Chen, MD, discusses the investigation of CDK4/6 inhibitors in early-stage breast cancer.

April 04, 2024

Rita Nanda, MD, discusses the future of neoadjuvant treatment for patients with HER2-positive breast cancer.

March 12, 2024

The University of Chicago Medicine treats patients with histotripsy, a technology that uses ultrasound energy to destroy liver tumors.

March 08, 2024

Sonali M. Smith, MD, discusses the value of mentorship in oncology practice on International Women’s Day.

March 08, 2024

Mecker G. Möller, MD, discusses the importance of addressing gender biases in oncology.

March 06, 2024

A new center at the University of Chicago Medicine will tackle health inequities in cancer.

March 05, 2024

Daniel Olson, MD, discusses the FDA approval of lifileucel for patients with advanced melanoma whose disease has been previously treated.

February 27, 2024

Daniel Olson, MD, discusses the significance of the FDA approval of lifileucel for patients with advanced melanoma.

January 08, 2024

Drs Donington and Stiles discuss the implications of perioperative immunotherapy trials on early-stage lung cancer management, definitions of resectability, and the incorporation of new multidisciplinary management guidance.